Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125744141 | 12574414 | 1 | I | 2004 | 20041203 | 20160720 | 20160720 | EXP | GB-GLAXOSMITHKLINE-B0360454A | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160720 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125744141 | 12574414 | 1 | PS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Unknown | 20 MG, UNK | U | 20031 | 20 | MG | |||||||
| 125744141 | 12574414 | 2 | SS | PAROXETINE HYDROCHLORIDE. | PAROXETINE HYDROCHLORIDE | 1 | Unknown | UNK | U | 0 | SUSPENSION FOR INJECTION | ||||||||
| 125744141 | 12574414 | 3 | SS | Seroxat | PAROXETINE HYDROCHLORIDE | 1 | UNK | U | 20031 | TABLET | |||||||||
| 125744141 | 12574414 | 4 | SS | PAROXETINE. | PAROXETINE | 1 | UNK | U | 0 | ORAL SOLUTION | |||||||||
| 125744141 | 12574414 | 5 | C | Levocetirizine | LEVOCETIRIZINE | 1 | U | 0 | |||||||||||
| 125744141 | 12574414 | 6 | C | Mizolastine | MIZOLASTINE | 1 | U | 0 | |||||||||||
| 125744141 | 12574414 | 7 | C | Pariet | RABEPRAZOLE SODIUM | 1 | U | 0 | |||||||||||
| 125744141 | 12574414 | 8 | C | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 125744141 | 12574414 | 9 | C | COCODAMOL | ACETAMINOPHENCODEINE PHOSPHATE | 1 | U | 0 | |||||||||||
| 125744141 | 12574414 | 10 | C | NAPROSYN | NAPROXEN | 1 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125744141 | 12574414 | 1 | Depression |
| 125744141 | 12574414 | 2 | Depression |
| 125744141 | 12574414 | 3 | Product used for unknown indication |
| 125744141 | 12574414 | 4 | Product used for unknown indication |
| 125744141 | 12574414 | 5 | Urticaria |
| 125744141 | 12574414 | 6 | Product used for unknown indication |
| 125744141 | 12574414 | 7 | Product used for unknown indication |
| 125744141 | 12574414 | 8 | Product used for unknown indication |
| 125744141 | 12574414 | 9 | Product used for unknown indication |
| 125744141 | 12574414 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125744141 | 12574414 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125744141 | 12574414 | Aggression | |
| 125744141 | 12574414 | Arthralgia | |
| 125744141 | 12574414 | Ataxia | |
| 125744141 | 12574414 | Diarrhoea | |
| 125744141 | 12574414 | Dizziness | |
| 125744141 | 12574414 | Drug withdrawal syndrome | |
| 125744141 | 12574414 | Hyperhidrosis | |
| 125744141 | 12574414 | Insomnia | |
| 125744141 | 12574414 | Loss of libido | |
| 125744141 | 12574414 | Myalgia | |
| 125744141 | 12574414 | Nightmare | |
| 125744141 | 12574414 | Palpitations | |
| 125744141 | 12574414 | Paraesthesia | |
| 125744141 | 12574414 | Suicidal ideation | |
| 125744141 | 12574414 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125744141 | 12574414 | 1 | 20010523 | 0 | ||
| 125744141 | 12574414 | 3 | 200009 | 0 | ||
| 125744141 | 12574414 | 6 | 200207 | 0 |